The Association of Community Cancer Centers, in collaboration with AstraZeneca, Merck, and partner organizations: the Association for Molecular Pathology, the National Society of Genetic Counselors, and the Society of Gynecologic Oncology, has launched the Barriers to Quality Care in Ovarian Cancer project.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
